{"created":"2023-05-15T14:36:26.585688+00:00","id":46927,"links":{},"metadata":{"_buckets":{"deposit":"71f81370-ef7d-457d-8c04-668b5ba64630"},"_deposit":{"created_by":1,"id":"46927","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"46927"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00046927","sets":["1"]},"author_link":["468332","468334","468331","468329","468333","468328","468327","468335","468336","468330"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2013-12","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{"bibliographic_title":"International journal of clinical oncology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The clinical usefulness of positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) for the detection of recurrent hepatocellular carcinoma (HCC) is controversial because HCC displays varying FDG avidity. The purposes of this study were to re-evaluate the utility of FDG PET for the detection of recurrent HCC, and to assess its prognostic value in a large series of postoperative patients.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Springer-Verlag Tokyo"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"24366329","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s10147-013-0653-3","subitem_relation_type_select":"DOI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1341-9625","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Hayakawa, Nobuyuki"}],"nameIdentifiers":[{"nameIdentifier":"468327","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nakamoto, Yuji"}],"nameIdentifiers":[{"nameIdentifier":"468328","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nakatani, Koya"}],"nameIdentifiers":[{"nameIdentifier":"468329","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hatano, Etsuro"}],"nameIdentifiers":[{"nameIdentifier":"468330","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Seo, Satoru"}],"nameIdentifiers":[{"nameIdentifier":"468331","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Higashi, Tatsuya"}],"nameIdentifiers":[{"nameIdentifier":"468332","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Saga, Tsuneo"}],"nameIdentifiers":[{"nameIdentifier":"468333","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Uemoto, Shinji"}],"nameIdentifiers":[{"nameIdentifier":"468334","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Togashi, Kaori"}],"nameIdentifiers":[{"nameIdentifier":"468335","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐賀 恒夫","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"468336","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-11-13"},"publish_date":"2014-11-13","publish_status":"0","recid":"46927","relation_version_is_last":true,"title":["Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:45:57.398341+00:00"}